Streamline FDA compliance with our CSV to CSA guide. Get it now!
Skip to content

Learn

What is GxP compliance? Standards and best practices

Learn what GxP compliance is, why it matters, and how GMP, GCP, and GLP guidelines help ensure quality and safety in regulated industries.

The pharmaceutical and life sciences sectors depend heavily on Good Practice (GxP) compliance. GxP is a set of regulations that ensure life science products, such as drugs and food, are safe for public use.

It includes implementing systems that ensure accuracy, consistency, and reliability in production. Adhering to GxP rules helps companies in this industry produce products suitable for use to ensure public safety. GxP compliance also demonstrates a company’s dedication to conducting itself ethically.

This post will examine GxP compliance, its importance, and best practices.

What is GxP compliance?

TL;DR: GxP is a set of regulatory guidelines that ensure products in industries like pharmaceuticals, food, and biotech are consistently safe, effective, and high quality through standardized processes and controls.

GxP compliance, also known as Good [x] Practices compliance, is a framework of regulations governing various (mainly regulated) industries, such as pharmaceuticals, medical devices, food, beverages, and biotechnology.

Compliance with GxP guidelines is primarily about maintaining product quality. GxP encompasses many requirements, like documentation practices, personnel training, and more.

Compliance with GxP reduces the likelihood of product recalls and other issues caused by inconsistent manufacturing.

Several organizations oversee GxP compliance around the world. Each administration has its rules and regulations for businesses within its purview.

The rules give organizations an idea of what they must do and best practices to ensure they stay within the law. It includes comprehensive guidelines on product testing, quality control, documentation practices, and more. Some well-known regulatory authorities include these:

Inspections and other regulatory activities are also part of these authorities’ responsibilities. They can check to see if businesses follow the rules, and take action if necessary.

These actions include levying fines, starting product recalls, or revoking operating licenses. Thus, regulated industries must stay current with regulatory requirements.

It’s a framework of regulations governing various (mainly regulated) industries.

Why is GxP compliance so important?

TL;DR: It safeguards public health, prevents costly recalls and penalties, builds trust, and is essential for entering and operating in regulated global markets.

GxP compliance is important because it serves as the primary safeguard between regulated industries and the public. In sectors like pharmaceuticals and medical devices, a single lapse in quality or safety can have severe, even fatal, consequences for patients.

Maintaining compliance isn’t just a legal obligation, it’s a foundational commitment to public health.

Business and regulatory impact of non-compliance

From a business standpoint, non-compliance carries serious financial and reputational risks. Regulatory actions such as warning letters, consent decrees, import bans, and forced product recalls can cost companies tens or hundreds of millions of dollars.

Beyond financial penalties, a publicized compliance failure can permanently damage consumer and investor confidence in a brand.

GxP compliance also plays a critical role in enabling global market access. Regulatory bodies in major markets, like the FDA in the United States and the EMA in Europe, require demonstrated compliance before a company can sell products within their jurisdictions.

A robust GxP program signals to these authorities that a company’s processes, data, and products can be trusted.

As the FDA/CDER noted when they began emphasizing quality by design: “It is important to recognize that quality cannot be tested into products; it should be built in by design.”

This principle encapsulates the purpose of GxP: compliance is not a checkpoint at the end of the manufacturing process but a continuous, system-wide commitment embedded in every procedure, record, and decision.

Finally, GxP compliance fosters a culture of accountability and continuous improvement within organizations. When employees at every level understand their role in maintaining compliance, quality becomes a shared responsibility rather than a siloed function.

This cultural dimension is often what separates organizations with strong compliance records from those that repeatedly encounter regulatory scrutiny.

The 5 P’s of GxP compliance

TL;DR: Effective compliance relies on five core elements—People, Processes, Products, Procedures, and Premises—all working together to maintain quality and control.

One practical framework for understanding the core requirements of GxP is the 5 P’s: People, Processes, Products, Procedures, and Premises. Together, these five elements represent the areas that regulated organizations must manage and control to maintain compliance.

1. People

Qualified, trained personnel are the backbone of any GxP-compliant operation. Every individual who contributes to a regulated product or study must understand their responsibilities and the standards they are required to uphold.

This includes not only technical staff but also management, quality assurance teams, and contractors.

2. Processes

GxP compliance requires that all critical processes are defined, validated, and consistently executed. Whether it’s a manufacturing workflow, a laboratory procedure, or a clinical trial protocol, processes must be designed to prevent errors and ensure reproducible results.

3. Products

The ultimate goal of GxP is to protect the quality and integrity of regulated products. This encompasses everything from raw material selection and in-process controls to final product testing and post-market surveillance.

4. Procedures

Standard Operating Procedures (SOPs) are the documented, step-by-step instructions that govern how tasks are performed within a GxP environment. They create uniformity across teams and sites, ensuring that outcomes do not depend on individual interpretation or habit.

5. Premises

The physical environment where regulated activities occur must be fit for purpose. This includes not only the design, maintenance, and cleanliness of facilities, but also the qualification and calibration of equipment used within them.

Understanding the 5 P’s helps organizations identify gaps in their compliance programs and prioritize remediation efforts.

The ultimate goal of GxP is to protect the quality and integrity of regulated products.

Key pillars of GxP compliance

TL;DR: Strong compliance programs are built on data integrity, proper documentation, controlled changes, proactive risk management, and continuous employee training.

While the 5 P’s describe the operational elements of GxP, the key pillars describe the underlying principles that hold a compliance program together. These pillars are consistent across virtually all GxP frameworks, regardless of the specific regulation or industry:

1. Data integrity

All data generated in a regulated context must be Attributable, Legible, Contemporaneous, Original, and Accurate. This is a set of principles commonly known by the acronym ALCOA. 

Data integrity failures are some of the most common causes of regulatory action worldwide and can invalidate entire studies or product batches.

2. Documentation

Comprehensive, accurate records are the evidence base for every compliance claim an organization makes. Without documentation, there is no way to verify that processes were followed, results were genuine, or decisions were justified.

3. Change control

Any modification to a validated process, system, or piece of equipment must go through a formal change control process. This ensures that changes are evaluated for their impact on product quality or safety before they are implemented.

4. Risk management

GxP programs must be built around a proactive approach to identifying, assessing, and mitigating quality risks. The International Council for Harmonization (ICH) Q9 guideline on Quality Risk Management provides a widely adopted framework for this.

5. Training

Personnel must be trained on the regulations, procedures, and systems relevant to their role—and that training must be documented, periodically refreshed, and verified as effective.

Benefits of GxP compliance

TL;DR: GxP improves product quality, ensures reliable data, enhances operational efficiency, reduces risks, and accelerates regulatory approvals and market access.

The benefits of GxP compliance include the following:

1. Continuous improvement

Continuous improvement is a core principle of GxP compliance. It encourages organizations to audit and assess their quality management systems regularly.

Continuous improvement also involves monitoring changes in regulatory requirements over time. It assists in identifying areas for improvement and ensures continuous adherence to rules.

2. Improved data quality

GxP compliance ensures that data is precise, complete, and current. It aids organizations in making wiser decisions based on reliable data.

3. Product quality and safety

Product quality and safety are paramount in GxP compliance. The GxP compliance policy ensures that consumers receive high-quality, safe products at all times.

It involves following standardized protocols in the manufacturing and research process. By following established protocols, products will be safe and effective.

4. Improved efficiency

GxP compliance eliminates unnecessary procedures and streamlines processes. It increases productivity by encouraging standardized procedures, documentation standards, and quality control measures.

By implementing these processes, organizations can improve efficiency, streamline operations, and reduce errors.

5. Increased market access

Often, entering new markets in regulated industries requires compliance with GxP regulations. Regulatory authorities in different countries also have their own GxP requirements. Organizations can hasten the regulatory approval process by complying with these GxP regulations.

Types of GxP compliance

TL;DR: GxP includes multiple frameworks like GCP, GMP, and GLP, each governing different stages such as clinical trials, manufacturing, and laboratory testing.

The following are examples of GxP compliance:

  1. Good Clinical Practices (GCP)
  2. Good Laboratory Practices (GLP)
  3. Good Manufacturing Practices (GMP)

Let’s take a closer look at each.

GCP ensures the ethical treatment of human subjects and the reliability of trial data.

What are Good Clinical Practices (GCP)?

TL;DR: GCP ensures clinical trials are conducted ethically, protects participants, and guarantees that collected data is accurate, reliable, and scientifically valid.

Good Clinical Practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve the participation of human subjects.

These rules govern clinical testing in the pharmaceutical, biologics, and medical device industries. GCP ensures the ethical treatment of human subjects and the reliability of trial data. It also guarantees that data collected during clinical trials is reliable and accurate.

Thus, we can trust and use the results to assess a drug’s effectiveness.

GCP embodies the following key principles:

1. Informed consent

Informed consent is a critical aspect of GCP, ensuring that participants are fully aware that they’re in a trial and can choose to participate. Patients should never feel coerced or compelled to take part in a trial against their will.

Thus, they should be educated about the nature of the trial, any benefits and risks, their rights, and more.

2. Data integrity

All data collected in a clinical trial must be precise and complete. Gathering trial data using standardized Case Report Forms (CRFs) and documentation is imperative. CRFs guarantee uniformity and consistency in data gathering across several trial locations.

GCP also recognizes the importance of electronic data capture (EDC) systems that allow electronic trial data entry and management instead of manual paper-based procedures.

3. Safety reporting

GCP strongly emphasizes the prompt reporting of safety data. It requires researchers to report adverse events during clinical trials to regulatory authorities.

These events include bodily injuries, unpleasant side effects, and more. Documenting these events ensures participant safety and timely evaluation of the events.

What are Good Manufacturing Practices (GMP)?

TL;DR: GMP ensures that products are consistently manufactured and controlled according to strict quality standards, minimizing risks like contamination and errors.

Good Manufacturing Practices (GMP) are a set of guidelines that govern the manufacturing, testing, and quality assurance of food, drugs, and medical device products to ensure they are safe, effective, and consistently produced to a high standard.

GMP aims to reduce the possibility of contamination and errors. GMP covers every facet of production, from the quality of raw materials to the quality of the final product. It also addresses employee training and the design and maintenance of production facilities.

GMP includes the following key principles:

1. Training

Personnel play an essential role in ensuring the quality of products. Employees must receive appropriate training to understand the industry practices outlined in GMP guidelines.

This training includes understanding GMP principles, equipment operation and maintenance, documentation practices, and more.

2. Quality control

Testing for quality control is a critical component of GMP. The process encompasses various activities, like analyzing raw materials, in-process testing, and more. It helps ensure that products meet quality standards and follow regulatory guidelines.

4. Control of raw materials

Raw material control ensures that organizations use only high-quality materials in manufacturing products. Organizations must buy raw materials from approved suppliers and verify their quality through testing and documentation.

GLP covers the design and reporting of laboratory tests, as well as the safety and accuracy of the results.

What are Good Laboratory Practices (GLP)?

TL;DR: GLP ensures laboratory studies are planned, conducted, and reported in a way that produces accurate, consistent, and trustworthy results.

Good Laboratory Practice (GLP) is a formal framework of regulations that governs the organizational process and conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, reported, and archived.

GLP applies to various industries like pharmaceuticals, chemicals, agrochemicals, and food additives. It covers the design and reporting of laboratory tests, as well as the safety and accuracy of the results.

As a result, we can rely on these results for making informed decisions about a product’s efficacy.

GLP is comprised of the following key principles:

1. Organization and personnel

In GLP, organizational structure and clearly defined roles and responsibilities are essential. All personnel involved in non-clinical studies must have the necessary qualifications and training. GLP promotes accountability, improves workflows, and guarantees efficient study conduct.

2. Facilities

GLP laboratories must be suitable facilities for conducting the required tests and procedures. An appropriate space requires good equipment, lighting, and ventilation. Enough space allows for experiments without overcrowding, reducing the chances of contamination.

3. Quality assurance

The quality assurance program is a fundamental principle of GLP. It focuses on developing a reliable system to track every facet of a non-clinical study. Thus, it aids laboratories in early problem detection, corrective action, and process improvement.

What are Good Documentation Practices (GDP)?

TL;DR: GDP ensures all records are accurate, complete, and traceable (ALCOA principles), making documentation a critical proof of compliance during audits.

Good Documentation Practices (GDP) are the standards and controls that govern how records are created, maintained, modified, and archived in a GxP-regulated environment.

GDP is a discipline that applies across all GxP frameworks (GCP, GMP, or GLP) and is often treated as a standalone compliance requirement in its own right.

The underlying premise is simple: if an activity cannot be proven through a record, it cannot be verified by a regulator, an auditor, or a quality team.

GDP requirements typically specify that all records must be:

  1. Attributable: It must be clear who performed an action or made an entry, and when.
  2. Legible: Records must be readable and permanent. Pencil entries, overwritten text, and illegible handwriting are common GDP violations.
  3. Contemporaneous: Entries should be made at the time the activity is performed, not reconstructed from memory after the fact.
  4. Original: The first recorded observation of an event is the authoritative record. Transcriptions and copies must be clearly identified as such.
  5. Accurate: Records must truthfully reflect the event or result being documented, with no omissions or alterations that could mislead a reviewer.

These principles, forming the ALCOA framework, are referenced in guidance from the FDA, EMA, and the World Health Organization (WHO).

In recent years, regulators have added two further attributes, Complete and Consistent, creating an extended ALCOA+ standard that is increasingly referenced in inspection findings.

GDP also governs how errors are corrected. A single line through a mistake, with the corrector’s initials and the date, is the accepted method for paper records. White-out, heavy overwriting, and backdating are all considered GDP violations with serious regulatory consequences.

GxP: If it isn’t documented, it didn’t happen

TL;DR: In regulated environments, undocumented work is treated as not done—only proper, real-time records can prove compliance to auditors and regulators.

While it may sound like an oversimplification, it reflects a regulatory reality. During inspections, auditors cannot accept verbal assurance or reconstructed accounts as evidence that a procedure was followed or a test was conducted. Only contemporaneous, attributable records carry evidentiary weight.

This principle has practical implications for every function in a GxP organization. A manufacturing operator who performs a critical in-process check but fails to record it has, from a compliance standpoint, not performed it.

A quality reviewer who identifies and communicates a deviation verbally but never raises a formal record has left the organization exposed.

The discipline of documentation is not bureaucratic overhead, it’s the mechanism by which regulated organizations demonstrate control over their processes to the outside world.

Organizations that internalize this principle tend to build stronger compliance cultures, because documentation becomes a natural reflex rather than an afterthought.

CSV is required whenever a computerized system is used to create, modify, maintain, archive, retrieve, or transmit GxP-relevant data.

What is Computer System Validation (CSV) for GxP?

TL;DR: CSV ensures that software systems used in regulated processes consistently perform as intended and meet regulatory requirements throughout their lifecycle.

As regulated industries have become increasingly reliant on software and automated systems, the validation of those systems has become a core GxP requirement.

Computer System Validation (CSV) is the process of establishing documented evidence that a computer system consistently produces results meeting predetermined specifications and quality attributes. 

More importantly, that evidence is in compliance with applicable GxP regulations.

CSV is required whenever a computerized system is used to create, modify, maintain, archive, retrieve, or transmit GxP-relevant data.

This includes a broad range of systems: laboratory information management systems (LIMS), electronic batch records, clinical data management systems, manufacturing execution systems (MES), and quality management systems (QMS), among others.

The CSV process typically follows a life cycle model that includes these phases:

1. Planning and risk assessment

The organization defines the scope and intended use of the system, and performs a risk assessment to determine the level of validation rigor required.

2. Requirement specification

User requirements and functional requirements are documented before the system is configured or installed. This establishes a baseline against which validation testing can be measured.

3. Design and configuration

The system is built or configured to meet the specified requirements.

4. Testing

Validation testing, including Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ), verifies that the system performs as intended under real-world conditions.

5. Ongoing maintenance

CSV is not a one-time activity. Any change to a validated system, whether a software update, configuration change, or infrastructure migration, must go through a documented change control process and may require revalidation.

Regulatory expectations for CSV are set out in FDA 21 CFR Part 11, which governs electronic records and electronic signatures, and in the EU Annex 11 to the GMP guidelines.

Both regulations emphasize that validated systems must include appropriate access controls, audit trails, and data backup and recovery procedures.

The rise of cloud-based software-as-a-service (SaaS) platforms in regulated environments has added new complexity to CSV programs.

Organizations must now assess not only the system itself but also the vendor’s infrastructure, security controls, and ability to support regulatory audit requirements.

Why training management is fundamental to GxP compliance

TL;DR: Continuous, role-based training ensures employees remain competent, compliant, and capable of maintaining quality standards in evolving regulatory environments.

Training is one of the most frequently cited observations in FDA warning letters and EMA inspection reports. Yet it remains one of the areas most prone to gaps in GxP-regulated organizations.

The reason is straightforward: unlike a piece of equipment that can be qualified once and monitored continuously, personnel require ongoing education, reinforcement, and assessment to remain competent.

Effective training management in a GxP context goes well beyond scheduling an annual refresher course. It encompasses the following:

1. Role-based curricula

Training must be tailored to the specific responsibilities of each employee. A quality assurance analyst, a manufacturing technician, and a clinical data manager each require different training content, even if they share some foundational GxP principles.

2. SOP training and qualification

Any time a new or revised SOP is released, all affected personnel must be trained on it before they perform the associated task. This training must be documented, and the employee must demonstrate understanding through testing or observation before the training is considered complete.

3. Training effectiveness verification

Regulators increasingly expect organizations to verify that training has been effective, not merely completed. A signature on a training log is not sufficient if the employee cannot demonstrate competency in the relevant procedure.

4. Training records

All training activities must be documented and retained in individual training records. These records must be accessible during inspections and audits. Incomplete or missing training records are a common finding during regulatory inspections.

5. Training on regulatory changes

GxP regulations evolve over time. Organizations must have processes in place to identify relevant regulatory updates and train affected personnel promptly.

A modern learning management system (LMS) that is designed for GxP environments can significantly reduce the administrative burden of training management.

Such systems can automate training assignments based on job roles, track completion and assessment results, generate compliance reports, and flag overdue training items before they become inspection findings.

Ultimately, training management is fundamental to GxP compliance because it ensures that the human element of any regulated process—which is generally the most variable and difficult to control—is as consistent, capable, and accountable as the systems and procedures around it.

Organizations must perform regular audits to ensure compliance with GxP requirements. Audits can be internal or external.

Best practices for conducting GxP compliance

TL;DR: Maintain compliance through regular audits, strong documentation, SOPs, effective training, system validation, and structured CAPA processes.

To stay compliant, employ these best practices:

1. Audits

Organizations must perform regular audits to ensure compliance with GxP requirements. Audits can be internal or external. Company employees conduct internal audits, while third-party auditors conduct external audits.

GxP entails procedures for personnel training, equipment validation, documentation methods, and more. There’s no set time for conducting audits, but annual or biennial audits are most common. Company size, complexity, and noncompliance risk determine the audit frequency.

2. Training

Providing employees with training on GxP procedures and requirements is a must. This training should cover GxP principles, relevant regulations, and job-specific duties.

3. Documentation

GxP compliance requires accurate and extensive recordkeeping. It provides documentation of processes to ensure accountability across the organization.

These documents improve the internal organization processes for decision-making, communication, and regulatory compliance. Documentation must also be easily accessible, organized, and controlled.

4. Standard operating procedures (SOPs)

A company’s SOPs are essential to GxP compliance. SOPs provide precise, consistent instructions for carrying out necessary procedures and tasks.

These instructions should include specific details such as safety precautions and material requirements. SOPs enhance quality and ensure regulatory compliance. They must be reviewed and updated regularly to reflect changes in processes, regulations, or technology.

5. Computer system validation (CSV)

Any computerized system used in a GxP context must be validated before use and maintained in a validated state thereafter.

Organizations should maintain an inventory of GxP-relevant systems, assign validation ownership, and ensure that change control processes cover system updates and upgrades.

6. Deviation and CAPA management

When processes deviate from specifications or procedures, organizations must document the deviation, investigate its root cause, and implement Corrective and Preventive Actions (CAPAs) to address it.

A well-functioning CAPA system is one of the clearest indicators of a mature compliance culture.

Conclusion

A regulated organization’s commitment to GxP compliance is essential. It ensures that companies follow established regulations to maintain product quality and safety.

These regulations can be complex and challenging, especially for new organizations. However, organizations must follow these regulations to reduce risks and ensure safe products.

For software testing, check out the artificial intelligence-powered Tricentis platform. It’s totally automated, fully codeless, and intelligently driven by AI.

Tricentis testing solutions

Learn how to supercharge your quality engineering journey with our advanced testing solutions.

Author:

Guest Contributors

Date: Mar. 22, 2026

You may also be interested in...